Surrogacy4All’s medical and leadership team has authored a reproductive-medicine textbook, published peer-reviewed research indexed on PubMed, and earned two issued U.S. patents with four more applications pending. Surrogacy4All is a NYS-licensed (GSP220903), FDA-registered, physician-led surrogacy agency operating since 2006, with clinics in New York, Toronto, and Accra and programs from $120,000.
| Credential | Details |
|---|---|
| Issued U.S. patents (leadership) | 2 — U.S. Patent Nos. 8,489,491 and 7,739,180 |
| U.S. patent applications pending | 5 — 1 published, 3 unpublished (D. Gulati); 1 published (Dr. R. Gulati) |
| Medical textbook | Foundations and Frontiers in Reproductive Medicine & Fertility (Patients Medical Education Press) |
| Peer-reviewed publications | PubMed-indexed systematic reviews — PMID 38912078; PMID 41625937 |
| Licensing | NYS License GSP220903 · FDA FEI #3021544308 |
| Operating since | 2006 · Clinics in New York, Toronto, and Accra |
| Program cost | Programs from $120,000; reconciled totals $120,500–$151,000 |
By Dr. Rashmi Gulati, MD, Medical Director, Patients Medical & Surrogacy4All, and Dr. Kulsoom Baloch, MBBS, MPH, MSHCM, Senior Coordinator, Egg Donor Program, Surrogacy4All.
The book spans the science and clinical practice of reproductive medicine — from foundational reproductive physiology through assisted reproductive technology, egg donation, and gestational surrogacy. It reflects the same clinical framework we apply in our own program: physician-led screening, evidence-based protocols, and coordination between the fertility clinic, the agency, and the obstetric team.
Members of our clinical team publish in indexed, peer-reviewed journals. Both systematic reviews below are co-authored by Dr. Kulsoom Baloch, MBBS, MPH, MSHCM, Senior Coordinator of our Egg Donor Program and co-author of our reproductive medicine textbook above. Both are on PubMed and can be read in full at the links below.
Parisa Aijaz, Kulsoom Farooqi Baloch, Haseeb Faiz, Abdul Karim Durvesh, Syeda Javeria Tirmizi, Maimoona Khan, Hassan Sohail, Saad Khalid, Muhammad A. Niazi, Amir Kamran. Cureus.
PMID: 38912078 Â |Â PMCID: PMC11194034 Â |Â DOI: 10.7759/cureus.62974
Parisa Aijaz, Balqees Ara, Haseeb Faiz, Kulsoom Farooqi Baloch, Rafi Aibani, Abdul Karim Durvesh, Maimoona Khan, Jennifer Collins, Amir S. Kamran. Cureus. 2025 Dec 30;17(12):e100444. eCollection 2025 Dec.
PMID: 41625937 Â |Â PMCID: PMC12854934 Â |Â DOI: 10.7759/cureus.100444
Systematic reviews are the most demanding form of medical literature: they require locating, appraising, and synthesizing every published case that meets inclusion criteria. The discipline that produces publishable systematic reviews is the same discipline we apply when we evaluate screening protocols and clinical evidence for our surrogacy and egg donation programs.
Our leadership team includes named inventors on two issued United States patents and five pending U.S. patent applications, all verifiable in public United States Patent and Trademark Office records. Patent inventorship reflects an original contribution examined and recognized by the USPTO. The entries below are professional credentials of the individuals named; nothing on this page is a claim that Surrogacy4All’s services are covered by any patent.
| Number | Title | Status | Date |
|---|---|---|---|
| U.S. Patent No. 8,489,491 | Method of Managing Financial Instruments, Equipment Lease Derivatives and Other Collateral Instruments, Data Architecture, Application and Process Program | Issued | July 16, 2013 |
| U.S. Patent No. 7,739,180 | Method of Managing Financial Instruments, Equipment Lease Derivatives and Other Collateral Instruments, Data Architecture, Application and Process Program | Issued | June 15, 2010 |
| U.S. Pat. App. Pub. No. 2026/0171257 | Systems and Methods for Multi-Modal Genetic, Biometric, and Psychometric Compatibility Scoring — including embodiments for donor and surrogate matching | Pending (published) | Filed Dec. 3, 2025; published June 18, 2026 |
| — | Three additional U.S. patent applications in health monitoring and AI verification technology | Pending (not yet published) | Filed 2026 |
| Number | Title | Status | Date |
|---|---|---|---|
| U.S. Pat. App. Pub. No. 2022/0387533 | Compositions and Methods for Dietary Management of Immune Health | Pending (published) | Published Dec. 8, 2022 |
Yes. Surrogacy4All holds New York State License GSP220903 and FDA registration FEI #3021544308, and has operated since 2006 with clinics in New York, Toronto, and Accra.
Dr. Rashmi Gulati, MD, Medical Director of Patients Medical since 2004, is the Medical Reviewer for all Surrogacy4All content and oversees the medical standards of our programs.
Yes. Dr. Rashmi Gulati, MD and Dr. Kulsoom Baloch, MBBS, MPH, MSHCM co-authored Foundations and Frontiers in Reproductive Medicine & Fertility (Revised and Expanded Academic Edition), published by Patients Medical Education Press.
Yes. Leadership members are named inventors on two issued U.S. patents (Nos. 8,489,491 and 7,739,180) and five pending U.S. patent applications, including a published application covering multi-modal compatibility scoring with donor and surrogate matching embodiments.
No, and we say so plainly: the patents on this page are professional credentials of the individuals named, not claims that our surrogacy services are patent-protected. We list them because inventorship recognized by the USPTO is a verifiable indicator of the caliber of our team.
Check our NYS license with New York State’s licensing records, our FDA registration in the FDA database, the publications on PubMed using PMIDs 38912078 and 41625937, and the patents at the USPTO’s Patent Public Search using the numbers listed above.
Programs start from $120,000, with reconciled program totals of $120,500–$151,000 under our approved fee schedules. See our fees and cost page for the full breakdown.
Yes. Five manuscripts are in preparation, spanning surrogacy regulation, gestational carrier screening outcomes, South Asian oocyte donor programs, cross-border reproductive care, and nutrition in recurrent implantation failure. They are listed above with their current status and are labeled as works in progress until peer-reviewed publication.
Call (212) 661-7673 or email info@surrogacy4all.com for a free consultation. You will speak with our program team at 1148 5th Ave, Suite 1C, New York, NY 10128.
Our job is to listen, to connect the dots between your needs, and to determine how we can best help you have your baby. If you’re asking how much does it cost for a surrogate, we’ll walk you through every step of the process to ensure there are no surprises.
To make an appointment with one of our counselors or physicians, please call (212) 661-7673 or email info@surrogacy4all.com. We look forward to hearing from you.
Surrogacy4All is a unique international surrogacy service targeted at providing state of the art IVF and surrogacy services to Intended Parents irrespective of age, sex or color, at the lowest possible cost in the world.
Secret Guide to Minimizing Surrogacy Costs
All Rights Reserved to Surrogacy4all
